Equities

Ondine Biomedical Inc

OBI:LSE

Ondine Biomedical Inc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)6.38
  • Today's Change-0.125 / -1.92%
  • Shares traded2.10k
  • 1 Year change-25.00%
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2024 14:42 BST.
More ▼

Profile data is unavailable for this security.

About the company

Ondine Biomedical Inc. is a Canadian life sciences company. The Company is engaged in photodisinfection-based therapies to prevent and treat a range of infections, including those caused by drug-resistant pathogens. Its lead product, Steriwave, is a rapid nasal decolonization therapy that eradicates a broad spectrum of pathogens in the nose in only minutes. Steriwave enables rapid elimination of pathogens associated with healthcare-associated infections (HAIs), reduces the reliance on patient compliance and screening, and eliminates the generation of resistance associated with topical antibiotics and other antimicrobials. It also has several products in development, including treatment of chronic rhinosinusitis, decolonization of burns and wounds, disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia and the development of topical antiviral therapy for the upper respiratory tract, including the reduction of SARS-CoV-2 titre and transmission.

  • Revenue in GBP (TTM)917.99k
  • Net income in GBP-8.02m
  • Incorporated1996
  • Employees43.00
  • Location
    Ondine Biomedical Inc888-1100 Melville StVANCOUVER V6E 4A6CanadaCAN
  • Phone+1 60 4669 0555Fax+1 60 4669 0555
  • Websitehttps://ondinebio.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Rua Life Sciences PLC2.19m-1.44m9.00m33.009.00m33.00
Genincode PLC2.60m-5.94m9.29m36.009.29m36.00
Genedrive PLC272.00k-5.00m9.91m43.009.91m43.00
Renalytix PLC2.59m-35.24m13.70m80.0013.70m80.00
Verici DX PLC3.30m-3.67m15.65m19.0015.65m19.00
Inspiration Healthcare Group PLC34.30m-9.76m16.59m224.0016.59m224.00
Polarean Imaging PLC1.42m-6.52m16.91m29.0016.91m29.00
Ondine Biomedical Inc917.99k-8.02m17.66m43.0017.66m43.00
Abingdon Health PLC5.34m-2.24m17.91m82.0017.91m82.00
Belluscura PLC1.38m-14.18m20.64m35.0020.64m35.00
ANGLE plc2.02m-18.03m25.00m150.0025.00m150.00
Data as of Oct 04 2024. Currency figures normalised to Ondine Biomedical Inc's reporting currency: UK Pound GBX

Institutional shareholders

10.36%Per cent of shares held by top holders
HolderShares% Held
CRUX Asset Management Ltd.as of 12 Jan 20239.30m4.10%
Chelverton Asset Management Ltd.as of 31 Dec 20227.96m3.51%
Janus Henderson Investors UK Ltd.as of 31 Dec 20224.06m1.79%
Aegon Asset Management UK PLCas of 31 Jan 20241.13m0.50%
Premier Fund Managers Ltd.as of 30 Apr 20241.04m0.46%
More ▼
Data from 31 Dec 2023 - 31 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.